← Open Payments lookup

KONSTANTIN NIKIFOROV: Open Payments

NPI 1407967482 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,852 in 55 payments from 13 companies in 2025. Trend: 2023 $519 · 2024 $1,040 · 2025 $1,852

Food & beverage: $1,752Education: $100
CompanyPaymentsAmount
Axsome Therapeutics, Inc.7$343
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$299
ABBVIE INC.6$255
E.R. Squibb & Sons, L.L.C.3$198
Teva Pharmaceuticals USA, Inc.4$155
Alkermes, Inc.7$153
Vanda Pharmaceuticals Inc.4$114
Otsuka America Pharmaceutical, Inc.5$98
Takeda Pharmaceuticals U.S.A., Inc.4$78
Supernus Pharmaceuticals, Inc.3$63

Products named: Auvelity, CAPLYTA, VRAYLAR, COBENFY, REXULTI, FANAPT, LYBALVI, TRINTELLIX.

Industry payments across NY — which companies pay providers there.